First Header Logo Second Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Shapiro, Michael
Item TypeName
Concept Anticholesteremic Agents
Academic Article Targeting PCSK9 for therapeutic gains.
Academic Article Relationship Between Low-Density Lipoprotein Cholesterol and Lipoprotein(a) Lowering in Response to PCSK9 Inhibition With Evolocumab.
Academic Article Dyslipidaemia: The PCSK9 adventure - humanizing extreme LDL lowering.
Academic Article Application of PCSK9 Inhibitors in Practice.
Academic Article The PCSK9 revolution: Current status, controversies, and future directions.
Academic Article Future role of proprotein convertase subtilisin/kexin type 9 inhibitors in preventive cardiology.
Academic Article Diagnosing Resistance to a Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor.
Academic Article PCSK9 Inhibitors in Secondary Prevention-An Opportunity for Personalized Therapy.
Academic Article Children with Heterozygous Familial Hypercholesterolemia in the United States: Data from the Cascade Screening for Awareness and Detection-FH Registry.
Academic Article Efficacy and safety of bempedoic acid in patients with and without metabolic syndrome: Pooled analysis of data from four phase 3 clinical trials.
Academic Article Prolonged and Pronounced Low-Density Lipoprotein Cholesterol Lowering: The Gift That Keeps Giving.
Academic Article Discordant responses of plasma low-density lipoprotein cholesterol and lipoprotein(a) to alirocumab: A pooled analysis from 10 ODYSSEY Phase 3 studies.
Search Criteria
  • Anticholesteremic Agents